Nektar Therapeutics
Price & Volume
Stats
See more52W Range | $6.45-$66.92 |
Market Cap | $1.3B |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $62.6M |
Revenue Growth (YoY) | -51.1% |
Gross Profit (12 Mos) | $54.6M |
Diluted EPS | -$9.83 |
News
See moreYahoo Finance • 2 days ago
Autodesk upgraded, Nio downgraded: Wall Street's top analyst calls
Yahoo Finance • 21 days ago
Nektar outlines $1B market opportunity for REZPEG in alopecia areata as Phase III plans advance
Yahoo Finance • 22 days ago
Nektar Therapeutics Non-GAAP EPS of $1.85 beats by $4.64, revenue of $11.79M beats by $1.59M
Yahoo Finance • 2 months ago
These 2 Healthcare Stocks Are Up Over 100% in a Month. Can They Keep Climbing?
About
CEO | Mr. Howard W. Robin |
CFO | Ms. Sandra A. Gardiner |
Address | 455 Mission Bay Boulevard South, San Francisco, CA, United States, 94158 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 61 |
